GlaxoSmithKline (GSK) has entered into a significant partnership with LTZ Therapeutics to develop innovative treatments targeting hematologic cancers and solid tumors. This collaboration will leverage LTZ’s...
A new treatment for blood cancers, developed in a lab in Montreal, has shown promising results for patients, but remains unavailable in Canada. This experimental therapy,...
